1. Home
  2. VEON vs TVTX Comparison

VEON vs TVTX Comparison

Compare VEON & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VEON Ltd. ADS

VEON

VEON Ltd. ADS

SELL

Current Price

$76.76

Market Cap

5.3B

ML Signal

SELL

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

BUY

Current Price

$55.94

Market Cap

5.3B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
VEON
TVTX
Founded
1992
N/A
Country
United Arab Emirates
United States
Employees
18938
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
5.3B
IPO Year
2010
2013

Fundamental Metrics

Financial Performance
Metric
VEON
TVTX
Price
$76.76
$55.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
15
Target Price
★ $86.87
$75.21
AVG Volume (30 Days)
157.5K
★ 1.4M
Earning Date
11-06-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 92.89
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.96
$47.65
Revenue Next Year
$8.09
$49.39
P/E Ratio
$6.15
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$42.60
$22.59
52 Week High
$77.49
$68.73

Technical Indicators

Market Signals
Indicator
VEON
TVTX
Relative Strength Index (RSI) 73.81 33.71
Support Level $50.12 $53.76
Resistance Level N/A $59.93
Average True Range (ATR) 2.70 2.42
MACD 0.29 -0.78
Stochastic Oscillator 95.33 6.64

Price Performance

Historical Comparison
VEON
TVTX

About VEON VEON Ltd. ADS

VEON Ltd is a United Arab Emirates-based digital operator providing connectivity and Internet services to corporations and individuals. The company offers mobile and fixed-line telecommunications services through a range of traditional and broadband mobile technologies. The company's reportable segments consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. It provides its services under the Beeline, Kyivstar, Banglalink, and Jazz brands. It generates the majority of its revenue from Pakistan. Its telecommunications and digital services include voice, fixed broadband, data and cloud services.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: